FDA Conditionally Approves Merck Animal Health’s EXZOLTâ„¢ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)
Merck Animal Health Donates $20,000 to the University of Nebraska–Lincoln Klosterman Feedlot Innovation Center to Advance Sustainability-focused Research for Feedlot Cattle